(Abst.) Obesity affects disease activity and progression... in people w/MS on: November 14, 2024, 03:13:56 pm #1 From PubMed (November 14, 2024)--"Obesity affects disease activity and progression, cognitive functioning, and quality of life in people with multiple sclerosis": Obesity Affects Disease Activity and Progression, Cognitive Functioning, and Quality of Life in People With Multiple Sclerosis - PubMed In participants with MS, obesity was associated with faster disease progression, poorer health-related quality of life, and more rapid cognitive decline. Both overweight and obesity were associated... PubMed · pubmed.ncbi.nlm.nih.gov Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
